We are live on ! Find out more
BYAH

Park Ha Biological Technology Co

12 hedge funds and large institutions have $4.03M invested in Park Ha Biological Technology Co in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

505% more capital invested

Capital invested by funds: $666K → $4.03M (+$3.36M)

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

200% more funds holding

Funds holding: 412 (+8)

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
12
Holders Change
+8
Holders Change %
+200%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
1
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

BYAH Hedge Fund Activity: Q2 2025 in Review

12 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Park Ha Biological Technology Co (BYAH) for Q2 2025, worth a combined $4.03M — up 505% from $666K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BYAH positions and 2 closed out — a net gain of 8 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Invesco, opening a new position worth an estimated $349K. The largest seller was HRT Financial, exiting entirely with an estimated $195K sold.

  • 12 institutional investors held Park Ha Biological Technology Co (BYAH) as of Q2 2025, up from 4 in Q1 2025.
  • Funds reported $4.03M of Park Ha Biological Technology Co stock for Q2 2025, up 505% quarter-over-quarter.
  • 10 funds opened new Park Ha Biological Technology Co positions in Q2 2025 and 2 closed out, a net change of +8 holders.
  • The largest Park Ha Biological Technology Co buyer in Q2 2025 was Invesco, an estimated $349K added.
  • The largest Park Ha Biological Technology Co seller in Q2 2025 was HRT Financial, an estimated $195K sold.

Based on aggregated 13F filings for Q2 2025.